Molecular target of seratonin neurotransmission - implication in therapeutics of mood disorders

被引：0
|
作者：
Li, X.
机构：
来源：
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY | 2012年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
S-27-001
引用
收藏
页码：31 / 31
页数：1
相关论文
共 50 条
  • [21] Twist: a molecular target in cancer therapeutics
    Khan, Md Asaduzzaman
    Chen, Han-chun
    Zhang, Dianzheng
    Fu, Junjiang
    TUMOR BIOLOGY, 2013, 34 (05) : 2497 - 2506
  • [22] Neuroplasticity as a target for the pharmacotherapy of anxiety disorders, mood disorders, and schizophrenia
    Krystal, John H.
    Tolin, David F.
    Sanacora, Gerard
    Castner, Stacy A.
    Williams, Graham V.
    Aikins, Deane E.
    Hoffman, Ralph E.
    D'Souza, D. Cyril
    DRUG DISCOVERY TODAY, 2009, 14 (13-14) : 690 - 697
  • [23] Inflammation as a treatment target in mood disorders: review
    Jones, Brett D. M.
    Daskalakis, Zafiris J.
    Carvalho, Andre F.
    Strawbridge, Rebecca
    Young, Allan H.
    Mulsant, Benoit H.
    Husain, M. Ishrat
    BJPSYCH OPEN, 2020, 6 (04):
  • [24] Emotional cognition heterogeneity in patients with mood disorders and clinical implication
    Varo, C.
    Kjaerstad, H. L.
    Poulsen, E.
    Meluken, I.
    Vieta, E.
    Vinberg, M.
    Kessing, L. V.
    Miskowiak, K. M.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2020, 40 : S170 - S171
  • [25] Glutamatergic neurotransmission: A potential pharmacotherapeutic target for the treatment of cognitive disorders
    Chakraborty, Pratik
    Dey, Abhijit
    Gopalakrishnan, Abilash Valsala
    Swati, Kumari
    Ojha, Shreesh
    Prakash, Anand
    Kumar, Dhruv
    Ambasta, Rashmi K.
    Jha, Niraj Kumar
    Jha, Saurabh Kumar
    Dewanjee, Saikat
    AGEING RESEARCH REVIEWS, 2023, 85
  • [26] Molecular genetic findings in mood disorders
    Souery, D
    Mendlewicz, J
    ACTA NEUROPSYCHIATRICA, 1999, 11 (02): : 67 - 70
  • [27] Genetic Studies on the Tripartite Glutamate Synapse in the Pathophysiology and Therapeutics of Mood Disorders
    de Sousa, Rafael T.
    Loch, Alexandre A.
    Carvalho, Andre F.
    Brunoni, Andre R.
    Haddad, Marie Reine
    Henter, Ioline D.
    Zarate, Carlos A., Jr.
    Machado-Vieira, Rodrigo
    NEUROPSYCHOPHARMACOLOGY, 2017, 42 (04) : 787 - 800
  • [28] Targeting glutamatergic transmission in the development of novel therapeutics for mood and anxiety disorders
    Sanacora, G.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2013, 23 : S142 - S142
  • [29] RNA therapeutics for mood disorders: current evidence toward clinical trials
    Le Marois, Marguerite
    Tzavara, Eleni
    Ibrahim, El Cherif
    Blin, Olivier
    Belzeaux, Raoul
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2021, 30 (07) : 721 - 736
  • [30] Genetic Studies on the Tripartite Glutamate Synapse in the Pathophysiology and Therapeutics of Mood Disorders
    Rafael T de Sousa
    Alexandre A Loch
    André F Carvalho
    André R Brunoni
    Marie Reine Haddad
    Ioline D Henter
    Carlos A Zarate
    Rodrigo Machado-Vieira
    Neuropsychopharmacology, 2017, 42 : 787 - 800
12345